Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for A2RSQ0

Entry ID Method Resolution Chain Position Source
AF-A2RSQ0-F1 Predicted AlphaFoldDB

51 variants for A2RSQ0

Variant ID(s) Position Change Description Diseaes Association Provenance
rs3397423413 158 L>V No EVA
rs3397535019 181 I>KQILFETYKVSLLMS* No EVA
rs3388872455 212 H>L No EVA
rs3388878054 247 F>I No EVA
rs3397496836 272 R>G No EVA
rs3388878040 375 H>Q No EVA
rs3388856202 378 E>D No EVA
rs3388856183 380 P>R No EVA
rs3388875184 385 Q>E No EVA
rs3413151117 385 Q>H No EVA
rs3388877973 436 N>K No EVA
rs3388873321 454 I>L No EVA
rs3388869560 486 L>F No EVA
rs3388869172 524 T>S No EVA
rs3388869201 589 F>L No EVA
rs3388852238 625 E>D No EVA
rs3388869152 627 R>K No EVA
rs3397623090 629 M>I No EVA
rs3388865326 641 L>V No EVA
rs3388856212 680 A>T No EVA
rs3388878023 686 R>G No EVA
rs3388869233 703 K>T No EVA
rs3388860558 711 L>F No EVA
rs3397634789 714 N>K No EVA
rs3388869588 750 M>K No EVA
rs3388877994 794 L>Q No EVA
rs3388869565 807 L>P No EVA
rs3388865683 815 K>I No EVA
rs3388872488 888 S>Y No EVA
rs3388871989 916 L>P No EVA
rs3388856122 918 S>P No EVA
rs3388852167 968 T>I No EVA
rs3397566800 1013 V>A No EVA
rs3388869151 1017 I>N No EVA
rs3388869566 1022 Y>* No EVA
rs3388834694 1027 G>E No EVA
rs3388864467 1028 R>W No EVA
rs3388865329 1031 G>R No EVA
rs3388856182 1086 K>T No EVA
rs3388852251 1094 E>D No EVA
rs3388846983 1098 E>D No EVA
rs3388873335 1147 K>N No EVA
rs3388865346 1166 D>E No EVA
rs3388872479 1202 D>E No EVA
rs3388878002 1207 I>T No EVA
rs3388875175 1225 L>Q No EVA
rs3388871997 1227 E>* No EVA
rs3388875166 1231 I>N No EVA
rs3388834696 1236 E>D No EVA
rs3388860643 1236 E>Q No EVA
rs3388869571 1238 N>K No EVA

No associated diseases with A2RSQ0

6 regional properties for A2RSQ0

Type Name Position InterPro Accession
domain Coagulation factor 5/8 C-terminal domain 272 - 422 IPR000421-1
domain Coagulation factor 5/8 C-terminal domain 428 - 581 IPR000421-2
domain CUB domain 25 - 139 IPR000859-1
domain CUB domain 145 - 263 IPR000859-2
domain MAM domain 639 - 811 IPR000998
domain Neuropilin, C-terminal 847 - 923 IPR022579

Functions

Description
EC Number
Subcellular Localization
  • Membrane ; Single-pass membrane protein
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

1 GO annotations of cellular component

Name Definition
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.

2 GO annotations of molecular function

Name Definition
guanyl-nucleotide exchange factor activity Stimulates the exchange of GDP to GTP on a signaling GTPase, changing its conformation to its active form. Guanine nucleotide exchange factors (GEFs) act by stimulating the release of guanosine diphosphate (GDP) to allow binding of guanosine triphosphate (GTP), which is more abundant in the cell under normal cellular physiological conditions.
small GTPase binding Binding to a small monomeric GTPase.

1 GO annotations of biological process

Name Definition
positive regulation of triglyceride transport Any process that activates or increases the frequency, rate or extent of triglyceride transport.

4 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
O95248 SBF1 Myotubularin-related protein 5 Homo sapiens (Human) PR
Q6IQ26 DENND5A DENN domain-containing protein 5A Homo sapiens (Human) PR
Q6ZUT9 DENND5B DENN domain-containing protein 5B Homo sapiens (Human) PR
Q6PAL8 Dennd5a DENN domain-containing protein 5A Mus musculus (Mouse) PR
10 20 30 40 50 60
MSGSSAAPGP GSGSSPAACR FAHYFVLCGI DADSGLEPDE LAGENFDQSP LRRTFKSKVL
70 80 90 100 110 120
AHYPQNIEWN PFDQDAVNML CMPKGLSFRT QADNKEPQFH SFIITREDGS RTYGFVLTFY
130 140 150 160 170 180
EEVTSKQICT AMQTLYQMHN AEQYSSVYAS SSCSMDSLAS SIDEGDATSL LKLQRYNSYD
190 200 210 220 230 240
INRDTLYVSK SICLITPLPF MQACKKFLFQ LHKAVTSQQP PPLPLESYIH NILYEVPLPP
250 260 270 280 290 300
PGRSLKFYGV YEPVICQRPG PNELPLSDYP LREACELLGL ENLVQVFTCV LLEMQTLLYS
310 320 330 340 350 360
QDYQRLMTVA EGITTLLFPF QWQHVYVPIL PASLLHFLDA PVPYLMGLQS KEGTDRSKLE
370 380 390 400 410 420
LPQEANLCFV DIDNHFIELP EEFPQFPNKV DFIQELSEVL LQFGIPPEGS LHSSESATKL
430 440 450 460 470 480
KNMVLKDLAN DKKNGNVPNN SVSVYELLKG SETIARLQAL AKRTGVTMEK IDLPASLSEK
490 500 510 520 530 540
EKDLKLQCEE ADLRDSQLNV QLREVFANRF TQMFADYEAF VIQTAQDMES WLTNREQMQN
550 560 570 580 590 600
FDKASFLSDQ PEPYLPFLSR FIETQMFATF IDNKIMSQWE EKDPLLRVFD SRIEKIRLYN
610 620 630 640 650 660
VRAPTLRTSI YQKCSSLKEA AQSIEQRLMK MDHTAIHPHL LDMKIGQGKY EQGFFPKLQS
670 680 690 700 710 720
DVLATGPANN NRWVSRSATA QRRKERLRQS SEHIGLDSDL REKYMQEARS LGKNLRQPKL
730 740 750 760 770 780
SDLSPAVIAQ TNWKFVEGLL KECRMKTKRM LVEKMGHEAV ELGHGEANIT GLEENTLIAS
790 800 810 820 830 840
LCDLLERIWS HGLLVKQGKS ALWSHLLQFQ DREEKQEHLT DSPVALGPER RKSDSGVMLP
850 860 870 880 890 900
TLRVSLIQDM RHIQNMTEIK TDVGRARAWI RLSLEKKLLS QHLKQLLSNQ PLTKKLYKRY
910 920 930 940 950 960
AFLRCEEERE QFLYHLLSLN AVDYFCFTSV FTTIMIPYRS VIIPIKKLSN AIITSNPWIC
970 980 990 1000 1010 1020
VSGELGDTGV MQIPKNLLEM TFECQNLGKL TTVQIGHDNS GLLAKWLVDC VMVRNEITGH
1030 1040 1050 1060 1070 1080
TYRFPCGRWL GKGVDDGSLE RILIGELMTS ASDEDLGKQC RTPPQQKSPT TTRRLSITSL
1090 1100 1110 1120 1130 1140
TGKPAKPNAG QIQEGIGEAV NNIVKHFHKP EKERGSLTVL LCGENGLVAA LEQVFHHGFK
1150 1160 1170 1180 1190 1200
SARIFHKNVF IWDFVEKAVA YFETTDQILD NEGDVLIQKP SSKTFCHYVN AINTAPRNIG
1210 1220 1230 1240 1250 1260
KDGKFQILVC LGTRDHLLPQ WIPLLAECPA ITRMYEENAL LRDHMTVNSL IRILQTIQDF
1270
TIVLEGSLIK GVDV